This company listing is no longer active
Calliditas Therapeutics Temettü
Temettü kriter kontrolleri 0/6
Calliditas Therapeutics does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
n/a
Ödeme oranı
Sektör ortalama getirisi | 2.2% |
Bir sonraki temettü ödeme tarihi | n/a |
Eski temettü tarihi | n/a |
Hisse başına temettü | n/a |
Hisse başına kazanç | -US$8.89 |
Temettü verim tahmini | 0% |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Asahi Kasei To Pay A Fair Price For Calliditas Therapeutics
May 28Calliditas Therapeutics GAAP EPS of -SEK 3.62, revenue of SEK 64M
Aug 18Calliditas Therapeutics wins European approval for Kinpeygo for IgA nephropathy
Jul 15Calliditas submits nefecon marketing authorisation application to the EMA
May 28Calliditas shares rise 10% as FDA grants priority review for Nefecon
Apr 28Calliditas Therapeutics reports Q3 results
Nov 12Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if CALT's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if CALT's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
Calliditas Therapeutics Piyasaya Karşı Temettü Getirisi |
---|
Segment | Temettü Verimi |
---|---|
Şirket (CALT) | n/a |
Pazarın Alt %25'i (US) | 1.4% |
Pazarın En İyi %25'i (US) | 4.4% |
Sektör Ortalaması (Pharmaceuticals) | 2.2% |
Analist tahmini (CALT) (3 yıla kadar) | 0% |
Önemli Temettü: Unable to evaluate CALT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate CALT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate CALT's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as CALT has not reported any payouts.